Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia

This publication has 20 references indexed in Scilit:

• Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V Trial
  British Journal of Haematology, 1993
• Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid Leukemia
  New England Journal of Medicine, 1993
• Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma
  Leukemia Research, 1993
• Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications
  Annals of Hematology, 1992
• Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma
  British Journal of Haematology, 1991
• Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements
  British Journal of Haematology, 1986
• Serum deoxythymidine kinase in small cell carcinoma of the lung: Relation to clinical features, prognosis, and other biochemical markers
  Cancer, 1986
• Clinical analysis of 33 patients with adult T‐cell leukemia (ATL)‐diagnostic criteria and significance of high‐ and low‐risk ATL
  International Journal of Cancer, 1986
• Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.
  Proceedings of the National Academy of Sciences, 1981
• A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
  Biometrika, 1965